Russia’s health officials have given a go-ahead to testing a combination of the AstraZeneca shot and the single-dose version of the domestically developed Sputnik V vaccine, according to the country’s registry of approved clinical trials.The small study, scheduled to end in March next year, will enroll 150 volunteers and look at the mixed regimen’s safety and capability to trigger immune response.
Russia approves Sputnik-Astra vaccine combined trials
